Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.63 |
| ▸ | POLB | P06746 | 2/20 | 0.63 |
| ▸ | RAB9A | P51151 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | MGAM | O43451 | 1/20 | 0.61 |
| ▸ | AMY1A | P0DUB6 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 4/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.59 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29415439 | 1.00 | NPC1 (0.63) | NPC1POLBRAB9ALMNAMGAM | |
| SCHEMBL166484 | 0.86 | LMNA (0.82) | NPC1POLBRAB9ALMNASMN1; SMN2 | |
| SCHEMBL14082531 | 0.85 | LMNA (0.80) | NPC1POLBRAB9ALMNAALOX15 | |
| Hydrochloric Acid SCHEMBL27843329 | 0.84 | LMNA (0.80) | NPC1POLBRAB9ALMNASMN1; SMN2 | |
| SCHEMBL31311411 | 0.84 | THRB (0.59) | NPC1RAB9ATHRBALOX15SMN1; SMN2 | |
| SCHEMBL949170 | 0.83 | LMNA (0.73) | NPC1POLBRAB9ALMNASMN1; SMN2 | |
| SCHEMBL19380041 | 0.83 | TSHR (0.59) | NPC1RAB9ALMNAALOX15SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL28309203 | 0.81 | THRB (0.52) | NPC1RAB9AMGAMAMY1ATHRB | |
| SCHEMBL7078661 | 0.81 | LMNA (0.66) | NPC1POLBRAB9ALMNAALOX15 | |
| SCHEMBL12606939 | 0.80 | MELK (0.62) | NPC1POLBRAB9ALMNAALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4447895-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST ONE MEROCYANINE AND AT LEAST ASCORBIC ACID AND/OR A DERIVATIVE THEREOF | L'OREAL (FR) | 2024-10-23 | — | — | EP | claimed |
| WO-2023110763-A1 | COSMETIC AND/OR DERMATOLOGICAL COMPOSITION COMPRISING AT LEAST ONE MEROCYANINE AND AT LEAST ASCORBIC ACID AND/OR A DERIVATIVE THEREOF | L'OREAL (FR) | 2023-06-22 | — | — | WO | claimed |
| CN-109414382-B | Cosmetic composition containing 4- (3-ethoxy-4-hydroxyphenyl) butan-2-one and niacinamide compound | 莱雅公司 | 2021-12-10 | — | — | CN | claimed |
| US-20110046724-A1 | Expansible Biocompatible Coats Comprising a Biologically Active Substance | AVIDAL VASCULAR GMBH (DE) | 2011-02-24 | — | — | US | claimed |
| EP-2271396-A2 | EXPANSIBLE BIOCOMPATIBLE COATS COMPRISING A BIOLOGICALLY ACTIVE SUBSTANCE | Avidal Vascular Gmbh (DE) | 2011-01-12 | — | — | EP | claimed |
| WO-2009121565-A2 | EXPANSIBLE BIOCOMPATIBLE COATS COMPRISING A BIOLOGICALLY ACTIVE SUBSTANCE | AVIDAL VASCULAR GMBH (DE) | 2009-10-08 | — | — | WO | claimed |
| US-20050158271-A1 | Pharmaceutical applications of hydrotropic polymer micelles | AKINA, INC. | 2005-07-21 | — | — | US | claimed |
| US-20030031715-A1 | Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof | PURDUE RESEARCH FOUNDATION | 2003-02-13 | — | — | US | claimed |
| WO-2002030466-A2 | PHARMACEUTICAL APPLICATIONS OF HYDROTROPIC AGENTS, POLYMERS THEREOF, AND HYDROGELS THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2002-04-18 | — | — | WO | claimed |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | SYMRISE AG (DE) | 2026-02-12 | — | — | US | disclosed |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | SYMRISE AG (DE) | 2026-02-05 | — | — | US | disclosed |
| EP-4676433-A1 | LIQUID UV FILTER CONCENTRATE | Symrise AG (DE) | 2026-01-14 | — | — | EP | disclosed |
| EP-4676428-A1 | LIQUID UV FILTER COMPOSITION CONTAINING DIOLS | Symrise AG (DE) | 2026-01-14 | — | — | EP | disclosed |
| WO-2025132951-A1 | AQUEOUS COMPOSITION WITH A SENNOSIDE AND AT LEAST ONE HYDROTROPE AGENT | L'OREAL (FR) | 2025-06-26 | — | — | WO | disclosed |
| EP-2271396-A2 | EXPANSIBLE BIOCOMPATIBLE COATS COMPRISING A BIOLOGICALLY ACTIVE SUBSTANCE | Avidal Vascular Gmbh (DE) | 2011-01-12 | — | — | EP | disclosed |
| US-20100016219-A1 | Ophthalmic compositions containing solubilized cyclosporin | ZHANG JERRY | 2010-01-21 | — | — | US | disclosed |
| WO-2009121565-A2 | EXPANSIBLE BIOCOMPATIBLE COATS COMPRISING A BIOLOGICALLY ACTIVE SUBSTANCE | AVIDAL VASCULAR GMBH (DE) | 2009-10-08 | — | — | WO | disclosed |
| US-20050158271-A1 | Pharmaceutical applications of hydrotropic polymer micelles | AKINA, INC. | 2005-07-21 | — | — | US | disclosed |
| US-20030031715-A1 | Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof | PURDUE RESEARCH FOUNDATION | 2003-02-13 | — | — | US | disclosed |
| WO-2002030466-A2 | PHARMACEUTICAL APPLICATIONS OF HYDROTROPIC AGENTS, POLYMERS THEREOF, AND HYDROGELS THEREOF | PURDUE RESEARCH FOUNDATION (US) | 2002-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050158271-A1 | Pharmaceutical applications of hydrotropic polymer micelles | SLC46A1, SLC5A6, NAMPT | NPC1 782/4885POLB 1931/4885RAB9A 4342/4885 |
| US-20100016219-A1 | Ophthalmic compositions containing solubilized cyclosporin | FKBP8, SCARB1, FKBP2 | NPC1 1915/4885POLB 4237/4885RAB9A 4326/4885 |
| US-20260041094-A1 | Compositions Comprising an Antimicrobial Boosting Agent | TLR7, MYC, ERG28 | NPC1 979/4885POLB 2297/4885RAB9A 2162/4885 |
| US-20030031715-A1 | Pharmaceutical applications of hydrotropic agents, polymers thereof, and hydrogels thereof | HMGB2, HTT, ABCG2 | NPC1 2518/4885POLB 2081/4885RAB9A 3957/4885 |
| US-20260034042-A1 | Composition with Improved SPF and UVA Photoprotection | TYR, ERG28, CUTA | NPC1 2686/4885POLB 615/4885RAB9A 1541/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.